G01N 2333/91085
Transglutaminases
Official title: Transglutaminases; Factor XIIIq (2.3.2.13)
G01N2333/91085 (Transglutaminases) appears on 34 US grants and 39 published applications in this corpus.
Search patents in G01N- Granted patents
- 34
- Published applications
- 39
- Assignees
- 43
- Inventors
- 135
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 2 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 1 |
| 2002 | 1 | 0 |
| 2003 | 0 | 0 |
| 2004 | 1 | 0 |
| 2005 | 1 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 2 |
| 2011 | 0 | 2 |
| 2012 | 0 | 4 |
| 2013 | 1 | 1 |
| 2014 | 1 | 2 |
| 2015 | 2 | 4 |
| 2016 | 1 | 2 |
| 2017 | 1 | 1 |
| 2018 | 4 | 4 |
| 2019 | 0 | 1 |
| 2020 | 1 | 2 |
| 2021 | 1 | 2 |
| 2022 | 1 | 2 |
| 2023 | 1 | 1 |
| 2024 | 0 | 4 |
| 2025 | 1 | 2 |
| 2026 | 3 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Combination of markers for predicting the response to Vx-0018 Sep 2026US 12,728,158 B2Kriptic Pharmaceuticals Limited
- Biological markers in the diagnosis of endometriosis4 Aug 2026US 12,699,103 B2Yeditepe Universitesi
- tTG-DGP biomarkers for monitoring celiac disease30 Jun 2026US 12,669,510 B2Mayo Foundation for Medical Education and Research
- Factor XIII immunoassay4 Feb 2025US 12,216,130 B2Research Institute At Nationwide Children's Hospital
- Method and compositions for reducing immunorecognition of dietary protein16 May 2023US 11,647,762 B2Hill's Pet Nutrition, Inc.
- Method of detecting target substance, reagent, and in vitro diagnostic kit20 Aug 2026US 2026/0242844 A1Canon Kabushiki Kaisha
- Method for detecting and/or quantifying crosslinks formed by transglutaminases12 Jun 2025US 2025/0188509 A1Ucb Biopharma Srl
- Transglutaminase substrates for labeling8 May 2025US 2025/0147024 A1
- Mechanisms and predictors of adjuvanticity and antibody durability7 Nov 2024US 2024/0369540 A1The Board of Trustees of the Leland Stanford Junior University
- Biomarkers for the Detection of Thrombosis or Coagulation-Related Disorders and Their Applications1 Aug 2024US 2024/0255532 A1Yigong Ruisi Fujian Engineering Rescenter Co Ltd.
Most cited
By later US patents
- Biomarkers and targets for diagnosis, prognosis and management of prostate disease113US 5,972,615 AUrocor, Inc. · 1999
- Biomarkers and targets for diagnosis prognosis and management of prostate disease91US 6,171,796 B2Urocor, Inc. · 2001
- Pet leash with length-limited elastic section38US 5,873,328 A1999
- Method of determining blood coagulation factor XIII activity and kit of reagents for the determination18US 5,508,202 ANippon Shoji Kaisha, Ltd. · 1996
- Reagent for determination of blood coagulation factor XIII16US 4,624,927 AThe Green Cross Corporation · 1986